Abstract
This study aimed at identifying the oersistence od disease in patients with FMF treated with colchicine. Almost 30% of FMF patients display a persistent disease activity not fulfilling the definition of colchicine resistance, but impacting on their quality of life. In most of these patients colchicine is under-dosed and maximum recommended dose is rarely used.
Lingua originale | English |
---|---|
pagine (da-a) | 3218-3220 |
Numero di pagine | 3 |
Rivista | THE JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. IN PRACTICE |
Volume | 2021 |
DOI | |
Stato di pubblicazione | Pubblicato - 2021 |
Keywords
- Colchicine
- Familial Mediterranea fever